Raynaud's phenomenon in medical laboratory workers who work with solvents

Journal of Rheumatology

Volumn 38, Issue 9, 2011, Pages 1940-1946

  Purdie, Gordon L ^a   Purdie, Dianne J ^a   Harrison, Andrew A ^a  

^a UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

Hospital laboratories; Occupational diseases; Occupational exposure; Raynaud's phenomenon; Solvents; Xylenes

Indexed keywords

ACETONE; ALCOHOL DERIVATIVE; CHLOROFORM; FORMALDEHYDE; ORGANIC SOLVENT; TOLUENE; TRICHLOROETHYLENE; XYLENE;

ADULT; ARTICLE; COLD EXPOSURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LABORATORY PERSONNEL; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSISTANT; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCIENTIST;

ADULT; FEMALE; HUMANS; MALE; MEDICAL LABORATORY PERSONNEL; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; SOLVENTS;

EID: 80052316285     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101129     Document Type: Article

References (34)

1. Brennan P., Silman A., Black C., Bernstein R., Coppock J., Maddison P., et al. Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK Scleroderma Study Group. Br J Rheumatol 1993;32:357-361 (Pubitemid 23181985)
2. Spencer-Green G. Outcomes in primary Raynaud phenomenon:A meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998;158:595-600. (Pubitemid 28144816)
3. Koenig M., Joyal F., Fritzler M.J., Roussin A., Abrahamowicz M., Boire G., et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis:A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902-3912
4. Garnier R., Bazire A., Chataigner D. Systemic sclerosis and occupational exposure to solvents [French]. Arch Mal Prof Env 2006;67:488-504. (Pubitemid 44046695)
5. Kettaneh A., Al Moufti O., Tiev K.P., Chayet C., Toledano C., Fabre B., et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis:A metaanalysis of case-control studies. J Rheumatol 2007;34:97-103. (Pubitemid 46106568)
6. Czirjak L., Kumanovics G. Exposure to solvents in female patients with scleroderma. Clin Rheumatol 2002;21:114-118 (Pubitemid 34649591)
7. Lacey J.V. Jr., Garabrant D.H., Laing T.J., Gillespie B.W., Mayes M.D., Cooper B.C., et al. Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD). Am J Epidemiol 1999;149:761-770 (Pubitemid 29180785)
8. Czirjak L., Kiss C.G., Lovei C., Suto G., Varju C., Fuzesi Z., et al. Survey of Raynaud's phenomenon and systemic sclerosis based on a representative study of 10,000 south-Transdanubian Hungarianinhabitants. Clin Exp Rheumatol 2005;23:801-808 (Pubitemid 43040508)
9. Garabrant D.H., Lacey J.V. Jr., Laing T.J., Gillespie B.W., Mayes M.D., Cooper B.C., et al. Scleroderma and solvent exposure among women. Am J Epidemiol 2003;157:493-500. (Pubitemid 36292907)
10. Hipolito R.N. Xylene poisoning in laboratory workers:Case reports and discussion. Lab Med 1980;11:593-595
11. Maricq H.R., Carpentier P.H., Weinrich M.C., Keil J.E., Palesch Y., Biro C., et al. Geographic variation in the prevalence of Raynaud's phenomenon:A 5 region comparison. J Rheumatol 1997;24:879-889 (Pubitemid 27223622)
12. Wieslander G., Norback D., Edling C. Local cold exposure of the hands from cryosectioning work in histopathological and toxicological laboratories:Signs and symptoms of peripheral neuropathy and Raynaud's phenomenon. Occup Environ Med 1996;53:276-280 (Pubitemid 26121429)
13. Sterne J.A., White I.R., Carlin J.B., Spratt M., Royston P., Kenward M.G., et al. Multiple imputation for missing data in epidemiological and clinical research:Potential and pitfalls. BMJ 2009;338:b2393.
14. Liira J., Riihimaki V., Engstrom K., Pfaffli P. Coexposure of man to m-xylene and methyl ethyl ketone. Kinetics and metabolism. Scand J Work Environ Health 1988;14:322-327 (Pubitemid 18263668)
15. Vodickova L., Frantik E., Vodickova A. Neutrotropic effects and blood levels of solvents at combined exposures:Binary mixtures of toluene, o-xylene and acetone in rats and mice. Cent Eur J Public Health 1995;3:57-64.
16. Diot E., Lesire V., Guilmot J.L., Metzger M.D., Pilore R., Rogier S., et al. Systemic sclerosis and occupational risk factors:A case-control study. Occup Environ Med 2002;59:545-549 (Pubitemid 34864549)
17. Maitre A., Hours M., Bonneterre V., Arnaud J., Arslan M.T., Carpentier P., et al. Systemic sclerosis and occupational risk factors:Role of solvents and cleaning products. J Rheumatol 2004;31:2395-2401 (Pubitemid 39603087)
18. Nietert P.J., Sutherland S.E., Silver R.M., Pandey J.P., Knapp R.G., Hoel D.G., et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998;41:1111-1118 (Pubitemid 28265413)
19. Purdie G., Harrison A., Purdie D. Prevalence of Raynaud's phenomenon in the adult New Zealand population. N Z Med J 2009;122:55-62.
20. Pearce N., Checkoway H., Kriebel D. Bias in occupational epidemiology studies. Occup Environ Med 2007;64:562-568 (Pubitemid 47195177)
21. Vittinghoff E., McCulloch C.E. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007;165:710-718 (Pubitemid 46348374)
22. Sakakibara H., Hirata M., Hashiguchi T., Toibana N., Koshiyama H., Zhu S.K., et al. Digital sensory nerve conduction velocity and vibration perception threshold in peripheral neurological test for hand-arm vibration syndrome. Am J Ind Med 1996;30:219-224 (Pubitemid 26287195)
23. Jovanovic J.M., Jovanovic M.M., Spasic M.J., Lukic S.R. Peripheral nerve conduction study in workers exposed to a mixture of organic solvents in paint and lacquer industry. Croat Med J 2004;45:769-774 (Pubitemid 40052936)
24. Brown K.M., Middaugh S.J., Haythornthwaite J.A., Bielory L. The effects of stress, anxiety, and outdoor temperature on the frequency and severity of Raynaud's attacks:The Raynaud's Treatment Study. J Behav Med 2001;24:137-153 (Pubitemid 37490049)
25. Meyer-Baron M., Blaszkewicz M., Henke H., Knapp G., Muttray A., Schaper M., et al. The impact of solvent mixtures on neurobehavioral performance:Conclusions from epidemiological data. Neurotoxicology 2008;29:349-360
26. Greenstein D., Gupta N.K., Martin P., Walker D.R., Kester R.C. Impaired thermoregulation in Raynaud's phenomenon. Angiology 1995;46:603-611
27. Andersson K., Fuxe K., Toftgard R., Nilsen O.G., Eneroth P., Gustafsson J.A. Toluene-induced activation of certain hypothalamic and median eminence catecholamine nerve terminal systems of the male rat and its effects on anterior pituitary hormone secretion. Toxicol Lett 1980;5:393-398 (Pubitemid 11227471)
28. Lee T.F., Mora F., Myers R.D. Dopamine and thermoregulation:An evaluation with special reference to dopaminergic pathways. Neurosci Biobehav Rev 1985;9:589-598 (Pubitemid 16196294)
29. Hsieh G.C., Sharma R.P., Parker R.D. Hypothalamic-pituitary- adrenocortical axis activity and immune function after oral exposure to benzene and toluene. Immunopharmacology 1991;21:23-31.
30. Quan N., Xin L., Ungar A.L., Hunter W.S., Blatteis C.M. Validation of the hypothermic action of preoptic norepinephrine in guinea pigs. Brain Res Bull 1992;28:537-542
31. Herrick A.L. Pathogenesis of Raynaud's phenomenon. Rheumatology 2005;44:587-596 (Pubitemid 41487226)
32. Husain K., Vazquez M., Ansari R.A., Malafa M.P., Lalla J. Chronic alcohol-induced oxidative endothelial injury relates to angiotensin II levels in the rat. Mol Cell Biochem 2008;307:51-58 (Pubitemid 350238646)
33. Toda N., Ayajiki K. Vascular actions of nitric oxide as affected by exposure to alcohol. Alcohol Alcohol 45:347-355
34. Magnant J., De Monte M., Guilmot J.L., Lasfargues G., Diot P., Asquier E., et al. Relationship between occupational risk factors and severity markers of systemic sclerosis. J Rheumatol 2005;32:1713-1718 (Pubitemid 41324809)